
Lowe's Companies (LOW) stock may be set for a drop over the next quarter, based on unusually heavy LOW put options activity. However, analysts still have higher price targets and LOW is below historical metrics.
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

Lowe's Companies (LOW) stock may be set for a drop over the next quarter, based on unusually heavy LOW put options activity. However, analysts still have higher price targets and LOW is below historical metrics.

INOD is expanding into agentic reinforcement learning, winning AI programs and scaling enterprise tools as revenues surge and competition intensifies.

If you hold NVIDIA (NVDA) stock, one number deserves your attention: roughly a quarter. That is the share of fiscal 2028 business management expects from AI labs it will back with its own balance sheet. NVIDIA's revenue more than doubled year over year in fiscal Q2 2027, so this number is easy to miss. An important thing to watch is how much future demand depends on NVIDIA backing its own customers.

iRhythm's Q2 momentum, AI-driven predictive care and deeper EHR integration support growth, though reimbursement pressures remain.

Root extends its exclusive Carvana insurance deal through at least August 2028, strengthening embedded distribution as Direct competition intensifies.

Tuesday’s selloff echoes the garden-variety selloffs earlier this year, driven by anxiety over AI displacing traditional industries.

Dow Jones tech titan Amazon stock is battling with a key support level and approaching multiple new buy points.

The Nasdaq set a record on Tuesday morning while the Dow dropped 270 points. Neither move had much news behind it.

The tech-heavy index is on track for a second straight record close, while the Dow falls more than 250 points

Triple-digit growth, consecutive earnings beats, and a juicy technical setup back the bull case.

The artificial-intelligence trade is ripping once again, with tech stocks cresting fresh all-time highs, Wall Street bosses touting the scale of the investment race, and key players in the ecosystem downplaying existential risks from the world’s most important technology. Comments from JPMorgan’s Jamie Dimon on AI spending, pushback from Nvidia CEO Jensen Huang on AI risks, and surge in popularity of Meta Platform new AI agent Muse have all played a role in the tech resurgence. “There were lots worrying investors last week, and there still are,” said Ed Yardeni, founder and CEO of Yardeni Research.

The e-commerce tools provider is leaning into AI agent shopping.

The AI-driven data aggregation company still has a bright future.

Market Hang's panel talks about the challenges of organizing AI governance, the moral issues in the oversight process, and whether a third-party group, such as the pope, should be the solution. Defiance ETFs CIO Sylvia Jablonski, Gerber Kawasaki Wealth and Investment Management CEO Ross Gerber, Interactive Brokers Chief Strategist Steve Sosnick, and Yahoo Finance Executive Editor Brian Sozzi discuss.

These quality, low-volatility stocks yield between 2.4% and 3.1%, and have been raising their payouts for decades.

Micron Technology is IBD Stock Of The Day as the memory-chip maker surges above an early buy point ahead of its fiscal Q4 earnings report next week.

Viking Therapeutics surged more than 26% on fresh GLP-1 maintenance data while every major obesity peer from Eli Lilly to Novo Nordisk barely registered a pulse, raising a pointed question about whether this catalyst belongs to Viking alone or signals something bigger.

Rocket Lab commands a premium valuation that reflects investor confidence in its commercial momentum. Redwire is cheaper, improving fast, and often overlooked.
The move gives life sciences advertisers a more streamlined way to bring specialized healthcare audiences into their broader digital media strategies.

PWR offers broader infrastructure exposure and a $53.4B backlog, while STRL leads on momentum, valuation, ROIC and projected earnings growth.

The budget airline has been serving a key airport hub since 2006.

Expedia, Booking, and other travel stocks fell on worries that artificial personal assistants could siphon off some of their business.

A leaked document covering 546 employees in Oracle's cloud infrastructure division shows software developers made up about 17% of the cuts
Phong Le said market forces, not regulation, will push advanced AI models toward open source.

MHK fell 7% after CEO Jeff Lorberbaum's pre-retirement stock sales. With a reasonable valuation -- 11.9x 2026 EPS multiple with an 11.2% FCF yield -- mortgage-rate headwinds could pressure remodel demand into 2027. Risk-tolerant investors ought to buy now.
The multi-year partnership gives chip developers access to Teradyne’s advanced test systems as increasingly complex AI and next-generation semiconductor designs require more intensive evaluation before production.

Planet Labs PBC (PL) opened a new 5,700-square-meter satellite manufacturing facility in Berlin, hosting Germany’s Federal Minister for Economic Affairs and Energy. This marks a fresh operational milestone for the Earth observation specialist. For shareholders, Planet Labs PBC’s story has been mixed in the near term and strong over longer horizons. The 1-day and 7-day share price returns of 3.96% and 5.37% contrast with a 30-day share price decline of 23.42% and a 90-day slide of 40.17%. At...

Tesla (NasdaqGS:TSLA) faces a civil rights trial over racial harassment and discrimination claims tied to its Fremont Assembly plant. The case centers on allegations from Black workers who say they experienced racist slurs, graffiti and unequal treatment on the factory floor. Separately, Tesla and Sunrun coordinated what they describe as the largest residential distributed home battery dispatch event so far in California. Both the Fremont civil rights trial and the large Tesla Sunrun home...

Amgen (NasdaqGS:AMGN) reported positive Phase 3 trial results for dazodalibep in Sjögren's disease, targeting a major unmet autoimmune need. The company described dazodalibep as a potential first-in-class therapy, following successful outcomes in patients with Sjögren's disease. Amgen received an FDA label update for IMDELLTRA in extensive-stage small cell lung cancer, reducing recommended patient monitoring times. The dazodalibep Phase 3 success and IMDELLTRA monitoring change both reshape...

Applied Materials (AMAT) runs a services business, Applied Global Services, that grew 22% from a year earlier in its latest quarter. You probably think of the company as a seller of chipmaking machines, a business that rises and falls with factory spending. The stock is down 27% over the past three months. So how large is the services business.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.